According to a new report Global Endometrial Ablation Market, published by KBV research, The Global Endometrial Ablation Market size is expected to reach $1.3 billion by 2024, rising at a market growth of 5.8% CAGR during the forecast period.
The North America market would dominate the Global Hospitals Endometrial Ablation Market by Region by 2024, growing at a CAGR of 4.1 % during the forecast period. The Europe market is expected to witness a CAGR of 4.6% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 6.1% during (2018 - 2024).
The Radiofrequency Endometrial Ablation market dominated the Global Endometrial Ablation Market by Technology 2017. The Hydrothermal Ablation market is expected to witness a CAGR of 6.3% during (2018 - 2024). The Hysteroscopic Ablation market is expected to witness a CAGR of 6.6% during (2018 - 2024). Additionally, The Thermal Balloon Ablation market is expected to witness highest CAGR of 7.6% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/endometrial-ablation-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Smith & Nephew Plc., Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc., Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), AngioDynamics Inc.
Global Endometrial Ablation Market Segmentation
By Technology
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports: